{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:28:59Z","timestamp":1788488939598,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1124\/jpet.116.232694","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T00:06:02Z","timestamp":1459901162000},"page":"466-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["\u03b2-Lapachone Induces NAD(P)H:Quinone Oxidoreductase-1\u2013 and Oxidative Stress\u2013Dependent Heat Shock Protein 90 Cleavage and Inhibits Tumor Growth and Angiogenesis"],"prefix":"10.1016","volume":"357","author":[{"given":"Yougen","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.232694_bib1","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1158\/1535-7163.1021.3.8","article-title":"Altered Hsp90 function in cancer: a unique therapeutic opportunity","volume":"3","author":"Bagatell","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.116.232694_bib2","doi-asserted-by":"crossref","first-page":"e40795","DOI":"10.1371\/journal.pone.0040795","article-title":"Hsp90 is cleaved by reactive oxygen species at a highly conserved N-terminal amino acid motif","volume":"7","author":"Beck","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/jpet.116.232694_bib3","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.2174\/092986711796011256","article-title":"Molecular chaperone Hsp90 as a target for oxidant-based anticancer therapies","volume":"18","author":"Beck","year":"2011","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.116.232694_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s10637-010-9441-3","article-title":"Ascorbate\/menadione-induced oxidative stress kills cancer cells that express normal or mutated forms of the oncogenic protein Bcr-Abl. An in vitro and in vivo mechanistic study","volume":"29","author":"Beck","year":"2011","journal-title":"Invest New Drugs"},{"key":"10.1124\/jpet.116.232694_bib5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bcp.2008.10.019","article-title":"Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death","volume":"77","author":"Beck","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.116.232694_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00689804","article-title":"NAD(P)H:quinone oxidoreductase1 (DT-diaphorase) expression in normal and tumor tissues","volume":"12","author":"Belinsky","year":"1993","journal-title":"Cancer Metastasis Rev"},{"key":"10.1124\/jpet.116.232694_bib7","doi-asserted-by":"crossref","first-page":"36891","DOI":"10.1074\/jbc.274.52.36891","article-title":"Somatostatin increases glucocorticoid binding and signaling in macrophages by blocking the calpain-specific cleavage of Hsp 90","volume":"274","author":"Bellocq","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.232694_bib8","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nbt1415","article-title":"An orally delivered small-molecule formulation with antiangiogenic and anticancer activity","volume":"26","author":"Benny","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1124\/jpet.116.232694_bib9","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1073\/pnas.0702176104","article-title":"An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone","volume":"104","author":"Bey","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.116.232694_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.pharmtox.44.101802.121650","article-title":"Novel angiogenic signaling pathways and vascular targets","volume":"44","author":"Bicknell","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.116.232694_bib11","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1158\/0008-5472.CAN-08-4406","article-title":"Transcription inhibition of heat shock proteins: a strategy for combination of 17-allylamino-17-demethoxygeldanamycin and actinomycin d","volume":"69","author":"Cervantes-Gomez","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.116.232694_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/1535-7163.MCT-11-0648","article-title":"Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer","volume":"11","author":"Chen","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.116.232694_bib13","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00001813-200504000-00009","article-title":"In vivo efficacy and toxicity of intratumorally delivered mitomycin C and its combination with doxorubicin using microsphere formulations","volume":"16","author":"Cheung","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1124\/jpet.116.232694_bib14","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.freeradbiomed.2009.08.012","article-title":"Role of oxidative stress in geldanamycin-induced cytotoxicity and disruption of Hsp90 signaling complex","volume":"47","author":"Clark","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/jpet.116.232694_bib15","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1158\/0008-5472.CAN-10-1418","article-title":"Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation","volume":"70","author":"Dong","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.116.232694_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1158\/1078-0432.CCR-08-1691","article-title":"Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy","volume":"15","author":"Dong","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.116.232694_bib17","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1158\/0008-5472.CAN-07-6602","article-title":"Oxidative stress plays a critical role in inactivating mutant BRAF by geldanamycin derivatives","volume":"68","author":"Fukuyo","year":"2008","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.116.232694_bib18","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1200\/JCO.2005.12.085","article-title":"Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors","volume":"23","author":"Grem","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1124\/jpet.116.232694_bib19","doi-asserted-by":"crossref","first-page":"10536","DOI":"10.1158\/0008-5472.CAN-05-1799","article-title":"Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin","volume":"65","author":"Guo","year":"2005","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.116.232694_bib20","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/jnci\/djj300","article-title":"Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors","volume":"98","author":"Gyurkocza","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.116.232694_bib21","doi-asserted-by":"crossref","first-page":"27865","DOI":"10.1074\/jbc.M704312200","article-title":"Hip is a pro-survival substrate of granzyme B","volume":"282","author":"Hostetter","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.232694_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1535-6108(03)00029-1","article-title":"Heat shock protein 90 as a molecular target for cancer therapeutics","volume":"3","author":"Isaacs","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1124\/jpet.116.232694_bib23","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/jnci\/91.22.1940","article-title":"DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90","volume":"91","author":"Kelland","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/jpet.116.232694_bib24","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1078-0432.CCR-10-1983","article-title":"Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of \u03b2-lapachone for pancreatic cancer therapy","volume":"17","author":"Li","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.116.232694_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drup.2008.12.002","article-title":"New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential","volume":"12","author":"Li","year":"2009","journal-title":"Drug Resist Updat"},{"key":"10.1124\/jpet.116.232694_bib26","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1023\/A:1026143519395","article-title":"Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes","volume":"20","author":"Nasongkla","year":"2003","journal-title":"Pharm Res"},{"key":"10.1124\/jpet.116.232694_bib27","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1158\/1535-7163.MCT-10-0936","article-title":"(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis","volume":"10","author":"Pang","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.116.232694_bib28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1158\/0008-5472.CAN-08-2531","article-title":"Morelloflavone, a biflavonoid, inhibits tumor angiogenesis by targeting rho GTPases and extracellular signal-regulated kinase signaling pathways","volume":"69","author":"Pang","year":"2009","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.116.232694_bib29","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1158\/0008-5472.CAN-09-3201","article-title":"Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT\/mammalian target of rapamycin pathway","volume":"70","author":"Pang","year":"2010","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.116.232694_bib30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1568009023333854","article-title":"Cancer therapy with beta-lapachone","volume":"2","author":"Pardee","year":"2002","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1124\/jpet.116.232694_bib31","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1074\/jbc.275.8.5416","article-title":"NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity","volume":"275","author":"Pink","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.232694_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/excr.2001.5234","article-title":"beta-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1\/xip3","volume":"267","author":"Planchon","year":"2001","journal-title":"Exp Cell Res"},{"key":"10.1124\/jpet.116.232694_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ccr.2005.03.035","article-title":"Rational design of shepherdin, a novel anticancer agent","volume":"7","author":"Plescia","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1124\/jpet.116.232694_bib34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.cbpa.2010.03.019","article-title":"Discovery and development of Hsp90 inhibitors: a promising pathway for cancer therapy","volume":"14","author":"Porter","year":"2010","journal-title":"Curr Opin Chem Biol"},{"key":"10.1124\/jpet.116.232694_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0076-6879(04)82008-1","article-title":"NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics","volume":"382","author":"Ross","year":"2004","journal-title":"Methods Enzymol"},{"key":"10.1124\/jpet.116.232694_bib36","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1158\/1535-7163.MCT-10-0966","article-title":"Antitumor activity of the Hsp90 inhibitor IPI-504 in HER2-positive trastuzumab-resistant breast cancer","volume":"10","author":"Scaltriti","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.116.232694_bib37","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1073\/pnas.0711993105","article-title":"IP6K2 is a client for HSP90 and a target for cancer therapeutics development","volume":"105","author":"Shames","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.116.232694_bib38","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0891-5849(00)00310-5","article-title":"Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues","volume":"29","author":"Siegel","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/jpet.116.232694_bib39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1124\/jpet.116.232694_bib40","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/carcin\/14.8.1505","article-title":"Depression of catalase gene expression after immortalization and transformation of mouse liver cells","volume":"14","author":"Sun","year":"1993","journal-title":"Carcinogenesis"},{"key":"10.1124\/jpet.116.232694_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4161\/cbt.2.2.237","article-title":"Mu-calpain activation in beta-lapachone-mediated apoptosis","volume":"2","author":"Tagliarino","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.1124\/jpet.116.232694_bib42","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2887","article-title":"Targeting the dynamic HSP90 complex in cancer","volume":"10","author":"Trepel","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.116.232694_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.molmed.2003.12.005","article-title":"Altered states: selectively drugging the Hsp90 cancer chaperone","volume":"10","author":"Workman","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1124\/jpet.116.232694_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.canlet.2003.08.032","article-title":"Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone","volume":"206","author":"Workman","year":"2004","journal-title":"Cancer Lett"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524193214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.232694","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T14:45:18Z","timestamp":1739976318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524193214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0022356524193214"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.232694","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-Lapachone Induces NAD(P)H:Quinone Oxidoreductase-1\u2013 and Oxidative Stress\u2013Dependent Heat Shock Protein 90 Cleavage and Inhibits Tumor Growth and Angiogenesis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.232694","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}